ALZCF (Alzchem Group AG) EBIT: $113.4 Mil (TTM As of Mar. 2026)


ALZCF Alzchem Group AG ALZCF
66 GF Score
Price $199.80
! 5 Warning Signs
View Full Analysis

What is Alzchem Group AG EBIT?

Alzchem Group AG ALZCF 66 EBIT is $113.4 Mil as of Mar. 2026. GuruFocus rates ALZCF with a GF Score™ of 66/100. The stock has 5 warning signs investors should review.

Alzchem Group AG's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2026 was $30.0 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2026 was $113.4 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Alzchem Group AG's annualized ROC % for the quarter that ended in Mar. 2026 was 14.06%. Alzchem Group AG's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 27.51%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Alzchem Group AG's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 5.54%.

Alzchem Group AG  (OTCPK:ALZCF) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Alzchem Group AG's annualized ROC % for the quarter that ended in Mar. 2026 is calculated as:

ROC % (Q: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2025 ) + Invested Capital (Q: Mar. 2026 ))/ count )
=118.312 * ( 1 - 26.94% )/( (553.222 + 676.45)/ 2 )
=86.4387472/614.836
=14.06 %

where

Invested Capital(Q: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=723.278 - 80.72 - ( 89.336 - max(0, 139.232 - 347.377+89.336))
=553.222

Invested Capital(Q: Mar. 2026 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=756.62 - 0 - ( 80.17 - max(0, 161.213 - 364.916+80.17))
=676.45

Note: The Operating Income data used here is four times the quarterly (Mar. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

Alzchem Group AG's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2025  Q: Mar. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=120.072/( ( (327.836 + max(116.121, 0)) + (348.628 + max(80.254, 0)) )/ 2 )
=120.072/( ( 443.957 + 428.882 )/ 2 )
=120.072/436.4195
=27.51 %

where Working Capital is:

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(85.967 + 135.83 + 23.905) - (80.72 + 0 + 48.861)
=116.121

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(99.741 + 141.706 + 0.019999999999982) - (0 + 0 + 161.213)
=80.254

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Alzchem Group AG's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2026 )
=113.422/2047.407
=5.54 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alzchem Group AG EBIT Related Terms

Alzchem Group AG EBIT Historical Data

* Premium members only.

The historical data trend for Alzchem Group AG's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alzchem Group AG EBIT Chart

Alzchem Group AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 43.18 46.94 60.91 85.00 108.95

Alzchem Group AG Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 23.27 26.86 28.04 28.51 30.02

ALZCF vs LIN, SHW, ECL: EBIT Comparison

For the Specialty Chemicals subindustry, Alzchem Group AG's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Alzchem Group AG EV-to-EBIT vs Chemicals Industry

For the Chemicals industry and Basic Materials sector, Alzchem Group AG's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Alzchem Group AG's EV-to-EBIT falls into.


ALZCF
66GF Score
Alzchem Group AG ALZCF
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Alzchem Group AG EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $113.4 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of $113.4 Mil mean?
Alzchem Group AG (ALZCF) has a EBIT of $113.4 Mil as of Mar. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Alzchem Group AG.
Is Alzchem Group AG's EBIT too high?
Alzchem Group AG's current EBIT is $113.4 Mil. Overall, Alzchem Group AG has a GF Score™ of 66/100, reflecting its overall financial health beyond just this single metric.
How does Alzchem Group AG's EBIT compare to LIN and SHW?
Alzchem Group AG's EBIT of $113.4 Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Chemicals company?
A good EBIT depends on the Chemicals industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Alzchem Group AG. Alzchem Group AG's current EBIT is $113.4 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alzchem Group AG stock overvalued right now?
Alzchem Group AG (ALZCF) has a current EBIT of $113.4 Mil. The current EBIT is $113.4 Mil. Alzchem Group AG's overall GF Score™ is 66/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Alzchem Group AG (ALZCF), the current EBIT is $113.4 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Alzchem Group AG Business Description

Address Dr.-Albert-Frank-Street 32, Trostberg, DEU, 83308
Alzchem Group AG is an international chemical company. The reportable segments of the company are Specialty Chemicals, Basics and Intermediates, and Other Holdings. The specialty chemicals segment focuses on the production and distribution of high-quality growth products, and the basics and intermediates segment covers the production of basic and intermediate products. It generates a majority of its revenue from the Specialty Chemical segment. Geographically it serves Europe, Asia, and the Rest of the world whilst deriving substantial revenue from European Union.
66GF Score

Get the complete analysis for ALZCF

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$199.80
Price